CK
Chenthanmara Kp Nair
About Chenthanmara Kp Nair
Data last updated:
Chenthanmara Kp Nair is a Director at Apexio Pharma Private Limited (since 2023) and Additional Director at Lykmi Healthcare Private Limited (since 2024). The companies operate in Paper and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.40 Cr; the largest is Apexio Pharma Private Limited at ₹5.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apexio Pharma Private Limited U21001MH2023PTC416041 | Director | 26 Dec 2023 | 2023 | ₹5.47 Cr (FY 2025) | Active |
| Lykmi Healthcare Private Limited U24100MH2019PTC325091 | Additional Director | 01 Jul 2024 | 2019 | ₹1.94 Cr (FY 2024) | Active |
Board colleagues of Chenthanmara Kp Nair
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aarti Rohitash Maheshwari | 09545278 | Apexio Pharma Private Limited | Director |
| Paresh Shantilal Bagadia | 01636125 | Apexio Pharma Private Limited | Director |
| Payal Paresh Bagadia | 10439562 | Apexio Pharma Private Limited | Director |
| Sunaina Chentamara Nair | 08446190 | Lykmi Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chenthanmara Kp Nair
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chenthanmara Kp Nair
Chenthanmara Kp Nair currently holds 2 directorships: Apexio Pharma Private Limited (Director, since 26 Dec 2023, revenue ₹5.47 Cr (FY 2025)); Lykmi Healthcare Private Limited (Additional Director, since 01 Jul 2024, revenue ₹1.94 Cr (FY 2024)).
Chenthanmara Kp Nair was first appointed on 26 Dec 2023 as Director at Apexio Pharma Private Limited. The most recent appointment on record is 01 Jul 2024 at Lykmi Healthcare Private Limited.
The 2 current companies of Chenthanmara Kp Nair that report revenue have a combined latest revenue of ₹7.40 Cr: Apexio Pharma Private Limited ₹5.47 Cr (FY 2025); Lykmi Healthcare Private Limited ₹1.94 Cr (FY 2024).
The current boards of Chenthanmara Kp Nair's companies include Aarti Rohitash Maheshwari (Apexio Pharma Private Limited), Paresh Shantilal Bagadia (Apexio Pharma Private Limited), Payal Paresh Bagadia (Apexio Pharma Private Limited), Sunaina Chentamara Nair (Lykmi Healthcare Private Limited).